Delivery Order SPE2DR25D3303-SPE2DR26F67G2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,533 to AmerisourceBergen Drug Corp for Venofer 100 mg/5 mL vials on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order represents a direct purchase of the iron sucrose injection medication, which is commonly used to treat iron deficiency anemia in patients undergoing dialysis. The contract was placed to AmerisourceBergen's Corporate Office in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Infed 100 mg/2 mL vials with a contract ceiling value of $6,140.10. This firm fixed-price delivery order, which is scheduled for completion by December 15, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively procured with no set-aside designation and represents a child contract under...
- The Defense Logistics Agency awarded a $5,926.78 firm fixed price delivery order to AmerisourceBergen Drug Corp on November 4, 2025, for the supply of Venofer 100 mg/5 ml vials. This non-set-aside contract, with an ultimate completion date of November 5, 2025, represents a short-duration delivery order for this intravenous iron replacement therapy commonly used in the treatment of iron deficiency anemia, particularly in patients undergoing dialysis. The contract will be performed at...
- This delivery order, awarded August 4, 2025, to AmerisourceBergen Drug Corp represents a $10,075.02 firm fixed-price procurement of Infed 100 mg/2 mL vials for the Defense Department's Medical Supply Chain. The non-competitive delivery order will be performed in Conshohocken, Pennsylvania, with completion scheduled for August 5, 2025. As a child order under a larger contract vehicle, this award leverages AmerisourceBergen's established relationship with the Defense Logistics Agency for...
- The Defense Logistics Agency awarded a delivery order valued at $9,850.87 to AmerisourceBergen Drug Corp for the supply of Injectafer 750 mg/15 ml vials. This competitively awarded, firm fixed price delivery order was executed on December 22, 2025, with an ultimate completion date of December 23, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract involves no set-aside designation, indicating the award was made through open...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,613.40 for Injectafer 750 mg/15 mL vials on August 25, 2025, with completion scheduled for August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the company's Conshohocken, Pennsylvania location. The contract calls for the supply of this intravenous iron replacement therapy, which is used to treat iron deficiency anemia in...
- The Defense Logistics Agency awarded a $13,321.90 firm fixed price delivery order to AmerisourceBergen Drug Corp for Injectafer 750 mg/15 ml vials on October 31, 2025, with completion targeted for November 3, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award was made through open competition with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $20,753.19 to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Infed 100mg/2ml vials (10-count units). This firm fixed-price delivery order is scheduled for completion by December 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through competitive procurement with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $7,020.32 to AmerisourceBergen Drug Corp for the supply of Infed 100 mg/2 mL vials. This competitively awarded, firm fixed-price delivery order was issued on July 28, 2025, with an ultimate completion date of July 29, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Injectafer 750 mg/15 ml vials with a ceiling value of $8,747.15. This is a firm fixed-price delivery order with an ultimate completion date of December 22, 2025, issued under a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- SPE2DR25D3303Indefinite Delivery Contract
- SPE2DR25D3303-SPE2DR26F67G2Delivery Order
This delivery order, awarded on January 30, 2026, by the Defense Logistics Agency to AmerSourceBergen Drug Corp, provides iron sucrose 100 mg/5 mL vials valued at $1,412.09 with a firm fixed price. The order is a child contract under AmerSourceBergen's parent company Cencora, Inc., and carries an ultimate completion date of February 2, 2026. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract, indicating it was awarded on a full and open competitive basis. This delivery order operates under Cencora, Inc.'s significant Indefinite Delivery Contract with the DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2031. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide, including medications, vaccines, and specialized medical supplies. Iron sucrose, an intravenous iron replacement therapy, supports critical patient care needs across military treatment facilities and veteran healthcare programs managed through the Defense Health Agency's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 1/29/26 |